.png)
Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Pair it with nutrition support, movement, and regular monitoring
Lilly says tirzepatide is the first and only approved dual GIP and GLP-1 receptor agonist treatment to reduce excess body weight and maintain weight reduction long-term in combination with diet and exercise
Individual results at 2.5 mg vary based on genetics, baseline metabolic rate, diet adherence, and activity level
Similarly, the member states have adopted the WHO Acceleration Plan to stop obesity, supporting country-level action through 2030
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
